Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The city released a new list on Wednesday highlighting property owners with repeated and severe housing violations. Major changes to US pensions being considered by Congress Former cult members speak ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

PHOENIX — Prosecutors have agreed to create a statewide database of officers whose truthfulness or honesty may be questionable. But an attorney with the American Civil Liberties Union says it appears ...

The United States' 2025 National Security Strategy, which casts China as the US' primary competitor across different domains, reinforces the now familiar pattern in US policy thinking but with ...

A record number of patients in Northern Ireland are now waiting to see a hospital consultant for the first time with some now forced to wait almost six years. Figures just released show that ...